Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessVerisk Analytics’ Q2 Earnings Preview

Verisk Analytics’ Q2 Earnings Preview

Add to Favorite
Added to Favorite


Analysts at RBC Capital provided their outlook on Verisk Analytics, Inc. (NASDAQ:VRSK) ahead of the company’s upcoming Q2 earnings, which will be released on July 29.
The analysts expect Q2 revenues modestly below the Street estimates as the tailwinds from insurance premium growth and international travel are more than offset by a slowdown in workers comp, difficult comps from the Texas freeze, and Russia/Ukraine headwinds.
According to the analysts, Q2 margins will likely be impacted by the stranded costs along with similar margin headwinds in Q1, however, the analysts believe the financial divestiture should drive higher consolidated margins.
The analysts reduced their price target on the company’s shares to $210 from $227 but maintain the outperform rating as the defensive end-market and portfolio rationalization position the stock well in a choppy tape.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Thermo Fisher Scientific Reports Better Than Expected Q1 Results

Thermo Fisher Scientific (NYSE:TMO) announced its first-quarter earnings and...

Humana Drops 5 percent Despite Q1 Beat

Humana (NYSE:HUM) saw its shares drop by around 5%...

AT&T Reports Q1 EPS Beat, But Revenues Missed

AT&T (NYSE:T) reported its first-quarter earnings that exceeded analyst...